Lívia Maria Coelho de Carvalho Moreira

Lívia Maria Coelho de Carvalho Moreira

Auto-generated profile, based on publicly available information

Lívia Maria Coelho de Carvalho Moreira

Universidade Federal de Pernambuco

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ESEliadna de Lemos Vasconcelos Silva
Eliadna de Lemos Vasconcelos Silva
AOAntonia Carla Oliveira
Antonia Carla Oliveira
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
Edson Silva FilhoEdson Silva Filho
Edson Silva Filho
AWAlmir Gonçalves Wanderley
Almir Gonçalves Wanderley
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho

1 January 2024 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
ASAna Beatriz Almeida de Sousa Silva
Ana Beatriz Almeida de Sousa Silva
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Leishmaniasis is a neglected disease caused by the parasite of the genus Leishmania. Current treatment regimens are obsolete and cause several side effects, promoting poor patient compliance, in addition to the vast majority already having the potential for resistance. Therefore, polymeric nanoparticles emerge as one of the viable alternatives to overcome existing limitations, through passive or active vectorization. This review aims to summarize the latest studies of polymeric nanoparticles as an alternative treatment for leishmaniasis. In the first section, the main pharmacokinetic and pharmacodynamic challenges of current drugs are reported. The second section details how nanoparticles with and without functionalization are efficient in the treatment of leishmaniasis, discussing the characteristics of the polymer in the formulation. In this way, polymeric nanoparticles can improve the physicochemical properties of leishmanicidal drugs, improving solubility and stability, as well as improve the release of these drugs, directly or indirectly reaching monocytes/macrophages. 64.28% drugs were focused on the treatment of visceral leishmaniasis, and 28.57% on cutaneous leishmaniasis. The most chosen polymers in the literature are chitosan (35.71%) and PLGA (35.71%), the others represented 14.30% drugs, with all able to manage the drug release and increase the in vitro and/or in vivo efficacy of the original molecule. However, there are several barriers for these nanoformulations to cross laboratory research and is necessary more in-depth studies about the metabolites and degradation pathways of the polymers used in the formulations and plasma proteomics studies.

1 March 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
DMDemis Melo
Demis Melo
GGGabryella Garcia Guedes
Gabryella Garcia Guedes
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
The insertion of topical antimicrobials in wound treatment represented an important role in patient management. Among these agents, silver sulfadiazine (AgSD), introduced in the therapy of wounds and burns in the 1960s, is considered the gold standard in treatment due to its mechanism of action, in addition to its proven efficacy and safety. The association of AgSD with polymers for the development of curative formulations has been reported. The evaluation of the physical-chemical properties of these systems with the aid of analytical techniques of characterization is essential for the determination of their activities, besides allowing the detection of possible incompatibilities between AgSD and polymers. Thus, this review presents the main techniques of physicochemical characterization used in the evaluation of systems containing AgSD with curative purposes in order to provide parameters to ensure the efficacy and safety of these new therapeutic options. Microscopic, thermoanalytical, and spectroscopic techniques, for example, provide information on system properties such as surface chemical composition, crystallinity, morphology, and thermal stability of curative formulations containing AgSD. These techniques are important in the selection of the most appropriate techniques during the development of a polymeric curative system containing AgSD, in addition to providing information for cost reduction of a possible scale-up and the establishment of methodologies for quality control of these systems to ensure their efficacy and safety.

28 December 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
MRMysrayn Yargo de Freitas Araújo Reis
Mysrayn Yargo de Freitas Araújo Reis
EPElisana Afonso de Moura Pires
Elisana Afonso de Moura Pires
WRWilma Raianny Vieira da Rocha
Wilma Raianny Vieira da Rocha
MFMilen Maria Magalhães de Souza Fernandes
Milen Maria Magalhães de Souza Fernandes
The Psidium guajava is a species utilized traditionally to treat many pathologies for presenting a variety of phytochemicals, for: flavonoids, terpenoids, tannins, cineol, β-karyophylene. With the intent of exploring the pharmacological potential of P.guajava, its use for the creation of pharmaceutical products, an integrative review of the literature was made, using the guiding question: "How can the guava tree's therapeutic potential contribute to the development of new pharmaceutical products?". The searches ocurred in official documents and cientific articles indexed to the ANVISA data base of Scielo, PubMed and Lilacs, during the months of august and september of 2022. The describers used were: Phytotherapy, complementary therapies, Psidium, Therapeutic Action and Pharmaceutical Products being crossed with the help of operator And. Were considered as criteria of inclusion official documents and complete articles available for access, indexed to the aforementioned platforms, in english and portuguese, between 2012 and 2022, and as criteria of exclusion, duplicated studies, studies with thematic escape and that weren't available for access both free and in full, resulting in an atmosphere of 16 files. The researches has shown that the guava tree presents several therapeutic actions, such as: antioxidant, anti-inflammatory, photoprotective, antibacterial, anticariogenic, anti-tumor, antispasmodic, hypoglycemic, nephroprotective, anti-diarrheal, antinociceptive, healing, cytotoxic, and acts against dermatitis. Therefore, the bioactive compounds of this vegetable can be used for the development of pharmaceutical products with the purpose of expanding the therapeutic options in the market and optimize the patients' quality of life becoming fundamental to foster cientific researches that discuss about the safety, efficiency and toxicity of the using these metabolites.

1 June 2025 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
KSKayque Almeida dos Santos
Kayque Almeida dos Santos
LMLivia Maria Coelho de Carvalho Moreira
Livia Maria Coelho de Carvalho Moreira
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho
MSMonica F. L. R. Soares
Monica F. L. R. Soares
Introduction: Human Immunodeficiency Virus (HIV) infection is still a major global problem, whose drug treatment consists of prophylactic prevention and antiretroviral combination therapy for better pharmacological efficacy and control of the circulating virus. However, there are still pharmacological problems that need to be overcome, such as low aqueous solubility of drugs, toxicity, and low patient adherence. Drug delivery technologies can be used to overcome these barriers. Objective: This review summarized the latest drug delivery systems for HIV treatment. Initially, an overview of the current therapy was presented, along with the problems it presents. Then, the latest drug delivery systems used to overcome the challenges imposed in conventional HIV therapy were discussed. Conclusion: This review examines innovative approaches for HIV treatment, where various drug delivery systems have shown significant advantages, such as high drug encapsulation, improved solubility, and enhanced bioavailability both in vitro and in vivo. Strategies like cyclodextrins, solid dispersions, microneedles, and nanoparticles are explored to address challenges in drug solubility, bioavailability, and administration routes. Despite progress, obstacles like limited clinical trials and industrial scalability hinder the widespread adoption of these formulations, emphasizing the need for further research and collaboration to optimize and ensure accessibility of innovative HIV therapies, mainly in regions where access to HIV treatment is scarce and remains a challenge.

8 November 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
ECEduardo Valdivino da Costa
Eduardo Valdivino da Costa
FOFrancisco de Assis Silveira de Oliveira
Francisco de Assis Silveira de Oliveira
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
WRWilma Raianny Vieira da Rocha
Wilma Raianny Vieira da Rocha
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
Medicinal plants are used with several therapeutic applications, with hair disorders. Among the symptoms caused by these diseases, it is pertinent to emphasize the psychic damages such as loss of self-esteem and physical symptoms such as itching and burning. The present study aims to highlight the beneficial effect of medicinal plants against the symptoms caused by hair disorders. This is an integrative literature review using the Pubmed, Science direct and Google Scholar platforms and as descriptors “phytochemical”, “animal”, “seborrheic dermatitis”, “plant”, “anti-inflammatory extracts”, “antifungal” in English, crossed using the Boolean operators “AND” or “OR”. The selection of works took place after reading the title and abstract, with publication date between the years 2012-2022, excluding review studies, duplicate articles and thematic leakage. After extracting the data, 23 studies were selected that proved the effectiveness of plants on hair disorders, performing antifungal action (especially on fungi of the Malassezia spp. and Trichophyton spp.) and antioxidant due to the presence of phytochemical components such as flavonoids, phenolics, tannins, terpenoids, among others. It is noteworthy that most of these plants are processed using the maceration technique to obtain their extracts. Therefore, the bioactive compounds of these plants can be used for the development of pharmaceutical products with the purpose of expanding the therapeutic options on the market and optimizing the quality of life of patients, making it essential to encourage scientific research that discusses safety, efficacy and toxicity from the use of these metabolites.